Target intelligence / Profile preview

Tetratricopeptide repeat domain 1 (TTC1)

Target
TTC1
Molecular classification
Other (Tetratricopeptide repeat protein)
01

Overview

Tetratricopeptide repeat domain 1 (TTC1) is a protein that features tetratricopeptide repeats (TPR), which are structural motifs that mediate protein–protein interactions[1][3][5]. TTC1 functions prominently as an adaptor protein bridging the signaling between heterotrimeric G protein subunits and the small GTPase Ras, directly interacting with multiple Galpha subunits and preferentially binding to the active, GTP-bound form of Ras[1]. This adaptor role facilitates signal transduction from G protein-coupled receptors to downstream Ras-dependent mitogenic pathways such as ERK and IκB kinase activation. In addition to serving as a signaling scaffold, TTC1 also acts as a chaperone adaptor, promoting protein folding in synergy with chaperones like Hsp70 and Hsp40[1]. While TPR domain-containing proteins are implicated in a variety of cellular processes—including cell cycle regulation, transcriptional control, and mitochondrial function—TTC1 itself is chiefly recognized for its roles in maintaining proteostasis and regulating Ras signaling cascades[1][6]. TTC1 is a protein-coding gene (human gene symbol: TTC1, NCBI Gene ID: 7265), with mutations or dysregulation associated with conditions such as Seckel syndrome and inflammatory bowel disease[7]. No approved therapeutic drugs, mechanisms of action, or established biomarkers relating to TTC1 have been reported in current sources.

Other names
TPR1TPR repeat protein 1tetratricopeptide repeat domain 14833412C19RikLOC100130486
02

Biological functions

Protein–protein interaction scaffoldSignal transduction adaptor (bridging G protein-coupled receptors to Ras signaling)Protein folding co-chaperone (interacts with Hsp70 and Hsp40)
03

Disease associations

Cancer (inferred by involvement in Ras signaling, a pathway often dysregulated in cancer)Inflammatory bowel disease (associated)[7]Seckel syndrome (associated)[7]

Beyond the preview

Go deeper on Tetratricopeptide repeat domain 1 (TTC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetratricopeptide repeat domain 1 (TTC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call